MiniMed Group, Inc.
For the period ended Jul 31, 2026. Filed Sep 8, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jul 31, 2026 · Filed Sep 8, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2026-01-23; filed 2026-04-17.
0001628280-26-025777
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsCurrent report: 10-Q
Period ended 2026-07-31; filed 2026-09-08.
0001628280-26-060926
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 11 previous paragraphs and 4 current paragraphs.
3 unchanged; 1 reworded; 0 added; 7 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 0 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
The current filing states there were no material changes to risk factors.
This is the filer’s own statement, not a conclusion from the comparison. Read its qualifications and the report it references.
Current filing’s statement
There have been no material changes to our risk factors presented in our 2026 Form 10-K, under the section titled “Risk Factors”. For further discussion of our risk factors, refer to the section titled “Risk Factors” in our 2026 Form 10-K. Any of these factors could have a material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us, or that we currently deem immaterial may also impair our business or results of operations. References to past events are provided by way of example only and they or the lack of reference to any past event or example are not intended to be a representation as to whether or not such factors have occurred in the past or their likelihood of occurring in the future. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.
Removed paragraphs (7)
Previous report
A) Recent Sales of Unregistered Securities
Previous report
B) Use of Proceeds from our Initial Public Offering of Common Stock
Previous report
On March 5, 2026, our registration statement on Form S‑1 (File No. 333-292284) filed with the SEC relating to our IPO was declared effective by the SEC. The offering of 28,000,000 shares of our common stock at an initial public offering price of $20.00 per share commenced on March 5, 2026 and on March 9, 2026 we completed our IPO. Goldman Sachs & Co. LLC, BofA Securities, Inc., Citigroup Global Markets Inc. and Morgan Stanley & Co. LLC acted as the active bookrunners for the offering. Barclays Capital Inc., Deutsche Bank Securities Inc., Mizuho Securities USA LLC, Wells Fargo Securities, LLC, Evercore Group L.L.C. and Piper Sandler & Co. also acted as joint book running managers and BTIG, LLC and William Blair & Company, L.L.C. acted as co-managers. Following the sale of all 28,000,000 shares upon the closing of the IPO and the expiration of the over-allotment option with respect to up to an additional 4,200,000 shares, the offering terminated.
Previous report
The aggregate offering price of the common stock registered and sold under the registration statement was approximately $560 million. Net proceeds were approximately $538 million, after deducting underwriting discounts and commissions of approximately $22 million. We (i) retained $309 million of the net proceeds from the IPO such that, as of March 9, 2026, we had approximately $350 million of cash on hand, and (ii) used the excess of the net proceeds from the IPO over $309 million to repay (or cause one or more of the our subsidiaries to repay) intercompany debt owed to Medtronic under a note. As a result of the IPO, Medtronic currently owns approximately 90.03% of the outstanding shares of our common stock.
Previous report
There has been no material change in the planned use of the net proceeds from the offering as described in the section titled “Use of Proceeds” in the IPO Prospectus.
Previous report
C) Issuer Purchases of Equity Securities
Reworded paragraphs (1)
Previous wording
There have been no material changes to our risk factors presented in our IPO Prospectus under the section titled “Risk Factors,” which is incorporated by reference herein. For further discussion of our risk factors, refer to the section titled “Risk Factors” in the IPO Prospectus. Any of these factors could have a material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us, or that we currently deem immaterial may also impair our business or results of operations. References to past events are provided by way of example only and they or the lack of reference to any past event or example are not intended to be a representation as to whether or not such factors have occurred in the past or their likelihood of occurring in the future. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.
Current wording
There have been no material changes to our risk factors presented in our 2026 Form 10-K, under the section titled “Risk Factors”. For further discussion of our risk factors, refer to the section titled “Risk Factors” in our 2026 Form 10-K. Any of these factors could have a material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us, or that we currently deem immaterial may also impair our business or results of operations. References to past events are provided by way of example only and they or the lack of reference to any past event or example are not intended to be a representation as to whether or not such factors have occurred in the past or their likelihood of occurring in the future. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.